The VERV CVRVerve Therapeutics, Inc. – VERV
Pitch Summary: The author is skeptical about Verve Therapeutics’ potential to become a blockbuster due to the challenges of convincing stakeholders about the safety and efficacy of gene therapy for lowering LDL-C, especially when compared to existing treatments. BSD Analysis: The author highlights the competitive landscape with existing treatments like Merck’s oral drug and Inclisiran, […]
